These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28039736)

  • 1. Extensive Surgical Procedures Result in Better Treatment Outcomes for Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Osteoporosis.
    Kim HY; Lee SJ; Kim SM; Myoung H; Hwang SJ; Choi JY; Lee JH; Choung PH; Kim MJ; Seo BM
    J Oral Maxillofac Surg; 2017 Jul; 75(7):1404-1413. PubMed ID: 28039736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
    Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
    J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs).
    Holzinger D; Seemann R; Klug C; Ewers R; Millesi G; Baumann A; Wutzl A
    Oral Oncol; 2013 Jan; 49(1):66-70. PubMed ID: 22892237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws.
    Wutzl A; Pohl S; Sulzbacher I; Seemann R; Lauer G; Ewers R; Drach J; Klug C
    Head Neck; 2012 Feb; 34(2):194-200. PubMed ID: 21400630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.
    Mercer E; Norton T; Woo S; Treister N; Dodson TB; Solomon DH
    Calcif Tissue Int; 2013 Sep; 93(3):241-8. PubMed ID: 23756612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
    Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
    Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL; Kohn N
    J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S94-S100. PubMed ID: 26608159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.
    Bodem JP; Kargus S; Eckstein S; Saure D; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2015 May; 43(4):510-4. PubMed ID: 25841311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaws: Cohort study of surgical treatment results in seventy-four stage II/III patients.
    Pichardo SE; Kuijpers SC; van Merkesteyn JP
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1216-20. PubMed ID: 27421170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and bisphosphonate-related osteonecrosis in a dental school implant patient population.
    Al-Sabbagh M; Robinson FG; Romanos G; Thomas MV
    Implant Dent; 2015 Jun; 24(3):328-32. PubMed ID: 25764480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic cancer identified in osteonecrosis specimens of the jaws in patients receiving intravenous bisphosphonate medications.
    Carlson ER; Fleisher KE; Ruggiero SL
    J Oral Maxillofac Surg; 2013 Dec; 71(12):2077-86. PubMed ID: 23945512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw.
    Heufelder MJ; Hendricks J; Remmerbach T; Frerich B; Hemprich A; Wilde F
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):e429-35. PubMed ID: 23182374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases.
    Graziani F; Vescovi P; Campisi G; Favia G; Gabriele M; Gaeta GM; Gennai S; Goia F; Miccoli M; Peluso F; Scoletta M; Solazzo L; Colella G
    J Oral Maxillofac Surg; 2012 Nov; 70(11):2501-7. PubMed ID: 22883322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.